510(k) · Cleared
ClearedModification to Alkp
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Abbott Laboratories · CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes
Cleared on Dec 26, 2002 as substantially equivalent to K981806 (Abbott Laboratories, 1998) after a 42-day review. Its family tree reaches back 2 generations to 1982. 2 later devices descend from it.
- Decided
- Dec 26, 2002
- Review
- 42 days
- Class
- Class II
- Product code
- CJE
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K823213 (1982). 2 later devices descend from it, 2 citing it directly.
- Root · 2 generations backK823213 Diagnostics Alkaline Phosphatase OptimiBoehringer Mannheim Corp. · 1982
- 1 generation backK981806 ALKPAbbott Laboratories · 1998 · Recalled
- This deviceK023807 Modification to AlkpAbbott Laboratories · 2002
- Descendant · cites it directly · 0 of its ownK240468 Alkaline PhosphataseAbbott Laboratories Diagnostics Division · 2024
- Descendant · cites it directly · 0 of its ownK223317 Alkaline Phosphatase2Abbott Ireland Diagnostics Division · 2023
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K823213 | Diagnostics Alkaline Phosphatase Optimi | Boehringer Mannheim Corp. | 1982 | — |
| −1 | K981806 | ALKP | Abbott Laboratories | 1998 | 1 |
| 0 (this device) | K023807 | Modification to Alkp | Abbott Laboratories | 2002 | — |
| +1 | K240468 | Alkaline Phosphatase | Abbott Laboratories Diagnostics Division | 2024 | — |
| +1 | K223317 | Alkaline Phosphatase2 | Abbott Ireland Diagnostics Division | 2023 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CJE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CJE device
- #1 K251074 Tru Liver Health Test Panelscore 10.8 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K981806 | ALKPSummary page 1…line phosphatase in the sample. Substantial Equivalence: The modified Alkaline Phosphatase assay is substantially equivalent to the cleared Alkaline Phosphatase assay (K98 1806) on the AEROSET@System for the serum or plasma applications. The modifications included changes in the assay parameters for sampl… | 1998 |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 15.6 years on median.
- 1 of the 2 ancestors has a recall of any class.
- Of its descendants, K240468 (Abbott Laboratories Diagnostics Division, 2024) has gone furthest, with 0 descendants of its own.
How does its category compare?
All CJE devicesCJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CJE
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · CJE
Too few CJE 510(k)s in any year since 2007 to give a median.
Recalls per year · CJE
1in 2013
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CJE
10in 2025
MAUDE reports naming product code CJE, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 1 | — | 8 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 3 |
| 2011 | 2 | — | 1 | 24 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 2 | — | 1 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 2 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 1 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 0 | 6 |
| 2023 | 1 | — | 0 | 11 |
| 2024 | 1 | — | 0 | 11 |
| 2025 | 1 | — | 0 | 10 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Alkaline Phosphatase assay is intended to measure alkaline phosphatase in serum or plasma. Measurement of alkaline phosphatase is used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K023807 · printed Nov 6, 2026
Cite this page
510(k) Report. “K023807: Modification to Alkp.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023807
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026